Obesity medication lorcaserin activates brainstem glp-1 neurons to reduce food intake and augments glp-1 receptor agonist induced appetite suppression

HIGHLIGHTS

• who: Stefan Wagner from the The Rowett Institute, University of Aberdeen, Aberdeen, UK Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Medical Research Council Metabolic Diseases Unit, University of Cambridge, Cambridge, UK , have published the article: Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression, in the Journal: (JOURNAL) of December/23,/2022
• what: The authors report that PPGNTS neurons function as a necessary hub . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.